A federal court in Colorado has sided with a Catholic health care clinic in its challenge to a recent state law that forbids doctors and nurses from administering a natural hormone to reverse the effects of the first step of a medically induced abortion, which the state had implemented in part because of safety concerns.
Legal abortions most likely increased in the United States in the first six months of 2023 compared with 2020, according to a New York Times analysis of data from the Guttmacher Institute, which opposes abortion restrictions.
In a two-hour hearing on May 17 looking at the U.S. Food and Drug Administration’s decades-old approval of an abortion pill, federal judges seemed to have a harsher line of questioning for attorneys for the federal government and the drug maker, indicating they might be sympathetic to those challenging the drug’s availability.
A federal appeals court in Louisiana is hearing arguments May 17 about the accessibility of the abortion drug mifepristone.
An advisory panel of the Food and Drug Administration voted unanimously on May 10 to recommend that a birth control pill be sold in the U.S. without a doctor’s prescription.
The U.S. Supreme Court said April 14 it would temporarily keep in place status quo federal regulations regarding the use of an abortion drug, giving the court additional time to consider a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug.
“This is my fourth store!” an exasperated Lisa Shelton said as she stood in the aisle of a Rite Aid on 18th Avenue in Bensonhurst on Sunday, staring at a nearly-empty shelf that normally would be stocked with baby formula. Shelton, who gave birth to a baby boy last month, said she was down to her last two bottles of Similac and was feeling desperate.
The Food and Drug Administration (FDA) decision to lift restrictions on the abortion pill mifepristone — paving the way for women to obtain the pill by mail and self-perform abortions as early as 10 weeks of gestation without an in-person clinic visit — has drawn new criticism from pro-life advocates.
As COVID-19 continues to strike hundreds of thousands of Americans, there are disputes within the medical community on how to treat the drug and whether one particular drug is a cure for the virus.